Skip to main content

Boehringer Ingelheim – Schizophrenia

*STUDY UPCOMING- NOT RECRUITING*

The study is looking to investigate the cognition and functional capacity of patients with Schizophrenia

Sponsors: Boehringer Ingelheim

Phase : 2

Indication: Schizophrenia

Age: 18 years to 50 years

Category: Treatment

For more information regarding the study: https://clinicaltrials.gov/ct2/show/NCT02832037

Studies Currently Available At

Sign Up For This Study